Indiva

Indiva Reports Third Quarter Results Including Record Revenue and Positive Income From Operations

Retrieved on: 
Tuesday, November 21, 2023
Women, Seniors, Cannabis, Men, Specialty, Food, Beverage, Consumer, Retail, Natural Resources, Dark, Cream, Sale, Commitment, Marketing, The Red One, Supply, Analysis, FINANCIAL, POS, Growth, SKU, News, International, Cookie, Limited, Automation, Health Canada, Financial condition report, Result, No Future, EBITDA, Cannabinoid, THC, CBD, Stock, Bank statement, Conversation, Management, The, Research, Q3, Edible, Ageing, CBN, Red One, International Financial Reporting Standards, OCS, Cryptocurrency, Pharmaceutical industry, Video game, Warehouse, Silviculture, Security (finance), Maple syrup, Oil, Indiva, Pearl

"We are delighted to announce the best financial results in Indiva’s corporate history, driven entirely by organic growth, including record net revenue, record gross profit and gross margin, as well as positive EBITDA and positive income from operations.

Key Points: 
  • "We are delighted to announce the best financial results in Indiva’s corporate history, driven entirely by organic growth, including record net revenue, record gross profit and gross margin, as well as positive EBITDA and positive income from operations.
  • Gross revenue in Q3 2023 was a record $10.9 million, representing a 33.7% sequential increase from Q2 2023, and a 23.7% increase year-over-year from Q3 2022.
  • Year-to-date, net revenue increased 6.4% year-over-year to a record $26.7 million.
  • Year-to-date net revenue from edible products increased 0.8% year-over-year to a record $23.2 million or 86.9% of net revenue.

Indiva Reports Second Quarter 2023 Results

Retrieved on: 
Tuesday, August 29, 2023
Cannabis, Retail, Health, Natural Resources, General Health, Food, Beverage, Dark, Cream, Cannabis Act, Citrus, Marketing, International Financial Reporting Standards, Analysis, Management, Ageing, Supply, News, Automation, Lozenge, Edible, Pomegranate, FINANCIAL, No Future, OCS, Research, CBG, CBN, Limited, Growth, THC, International, Commitment, Financial condition report, Granny Smith, SKU, CBD, Farley's & Sathers Candy Company, Result, Bank statement, Cannabinoid, Health Canada, Conversation, Stock, Sale, EBITDA, Cryptocurrency, Gasoline, Pharmaceutical industry, Oil, Security (finance), Silviculture, Fine chemical, Doppio, Q2, Indiva, Pearl, Canopy

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the second fiscal quarter ended June 30, 2023.

Key Points: 
  • Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the second fiscal quarter ended June 30, 2023.
  • Gross revenue in Q2 2023 was $8.1 million, representing a 21.6% sequential decrease from Q1 2023, and an 8.5% decrease year-over-year from Q2 2022.
  • Data from Hifyre Inc. for the second quarter of 2023 shows strong sell-through of Indiva's edible products.
  • Baked Goods: Indiva led the baked goods category with 67.0% sub-category share, driven by the success of Doppio, formerly Indiva Life Double-Stuffed Sandwich Cookies.

Indiva Launches No Future Gummies and Vapes

Retrieved on: 
Thursday, August 10, 2023
Cannabis, Food, Beverage, Natural Resources, Retail, Specialty, Limited, No Future, THC, Drug, Oil, Indiva

No Future will initially launch with four flavours of THC gummies and three varieties of 1.2g 510 vapes.

Key Points: 
  • No Future will initially launch with four flavours of THC gummies and three varieties of 1.2g 510 vapes.
  • Similar to No Future gummies, Indiva expects this set of products to reset the floor price of legal 1.2g vapes across Canada.
  • No Future Vapes have been delivered in Alberta and are expected to land in Ontario on the same timeline as the gummies.
  • Indiva plans for more regions and product launches to come online in the fall and winter of 2023.

Indiva Announces Shareholder Meeting Results

Retrieved on: 
Thursday, July 20, 2023
Cannabis, Natural Resources, Other Retail, Retail, Specialty, SEDAR, Plan, Limited, Meeting, Russell Wilson, Indian stock exchange, Ernst & Young, Holding company, Security (finance), Indiva

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce the results of its annual general meeting of shareholders (the "Meeting").

Key Points: 
  • Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce the results of its annual general meeting of shareholders (the "Meeting").
  • At the Meeting, Indiva shareholders approved: (i) the re-election of the seven nominated directors, being Niel Marotta, Andre Lafleche, Hugh Hamish Sutherland, John Marotta, James Yersh, Russell Wilson and Rachel Goldman; (ii) the appointment of Ernst & Young LLP as the Company's auditors; and (iii) the adoption of the Company's amended and restated omnibus incentive plan (the "Plan").
  • The resolutions are fully described in the management information circular dated June 5, 2023 related to the Meeting, which can be found under the Company's SEDAR profile at www.sedar.com .
  • The Plan has been amended in order to increase the maximum number of common shares in the capital of the Company (the "Common Shares") reserved for issuance, in the aggregate, pursuant to the settlement of restricted share units granted under the Plan from 4,800,000 Common Shares to 12,000,000 Common Shares.

SNDL FILES EARLY WARNING REPORT ISSUED PURSUANT TO NATIONAL INSTRUMENT 62-103

Retrieved on: 
Thursday, June 22, 2023
Treasury, TSX Venture Exchange, AB, Related, National instrument, System, Indian stock exchange, SEDAR, TSX, News, Security (finance), Indiva

CALGARY, AB, June 22, 2023 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) ("SNDL") today announced that between June 10, 2023, and June 22, 2023, SNDL disposed of 3,297,000 common shares ("Common Shares") in the capital of Indiva Limited (TSXV: NDVA) (OTCQX: NDVAF) ("Indiva").

Key Points: 
  • CALGARY, AB, June 22, 2023 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) ("SNDL") today announced that between June 10, 2023, and June 22, 2023, SNDL disposed of 3,297,000 common shares ("Common Shares") in the capital of Indiva Limited (TSXV: NDVA) (OTCQX: NDVAF) ("Indiva").
  • Prior to the dispositions, SNDL held 19,235,500 Common Shares, representing approximately 12.93% of the then issued and outstanding Common Shares on a non-diluted basis.
  • Immediately following this disposition, SNDL now holds 15,938,500 Common Shares, representing 8.57% of Indiva's issued and outstanding Common Shares on a non-diluted basis, as reported to the TSX after taking into account various concurrent issuances by Indiva of Common Shares.
  • This news release is being issued to comply with National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues.

SNDL FILES EARLY WARNING REPORT ISSUED PURSUANT TO NATIONAL INSTRUMENT 62-103

Retrieved on: 
Saturday, June 10, 2023
Treasury, TSX Venture Exchange, AB, Related, National instrument, System, Indian stock exchange, SEDAR, News, Cryptocurrency, Security (finance), Indiva

CALGARY, AB, June 9, 2023 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) ("SNDL") today announced that between February 1, 2023, and June 9, 2023, SNDL disposed of 3,428,000 common shares ("Common Shares") in the capital of Indiva Limited (TSXV: NDVA) (OTCQX: NDVAF) ("Indiva").

Key Points: 
  • CALGARY, AB, June 9, 2023 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) ("SNDL") today announced that between February 1, 2023, and June 9, 2023, SNDL disposed of 3,428,000 common shares ("Common Shares") in the capital of Indiva Limited (TSXV: NDVA) (OTCQX: NDVAF) ("Indiva").
  • Prior to the dispositions, SNDL held 22,663,500 Common Shares, representing approximately 15.59% of the then issued and outstanding Common Shares on a non-diluted basis.
  • Immediately following this disposition, SNDL now holds 19,235,500 Common Shares representing 12.93% of Indiva's issued and outstanding Common Shares on a non-diluted basis as reported to the TSXV.
  • This news release is being issued to comply with National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues.

CANOPY GROWTH AND INDIVA ANNOUNCE AGREEMENT TO POSITION WANA GUMMIES FOR CONTINUED NORTH AMERICAN BRAND LEADERSHIP

Retrieved on: 
Tuesday, May 30, 2023
Edible, Partnership, TSX Venture Exchange, Indian stock exchange, Private placement life insurance, Private, Marketing, Placement, Issue, Person, Sale, EBITDA, Investment, Growth, TSX, Policy, Private placement, News, Automation, Silviculture, Security (finance), Canopy Growth, Indiva, Canopy

David Klein, CEO of Canopy Growth, said, "Collectively, these agreements provide Canopy Growth more complete ownership over the value chain for the Wana brand in Canada, while ensuring continuity of high-quality manufacturing and consistency with Canopy's asset-light production strategy.

Key Points: 
  • David Klein, CEO of Canopy Growth, said, "Collectively, these agreements provide Canopy Growth more complete ownership over the value chain for the Wana brand in Canada, while ensuring continuity of high-quality manufacturing and consistency with Canopy's asset-light production strategy.
  • We expect this arrangement to be immediately accretive to Canopy Growth's EBITDA, and we look forward to partnering with Indiva to further bolster Wana's position as a leading edible brand in Canada."
  • "We are excited to form this investment and contract manufacturing partnership with Canopy Growth, and we look forward to continuing to produce Wana gummies for many years to come," said Niel Marotta, President and CEO of Indiva.
  • Canopy Growth and Indiva will also enter into a customary standstill and voting support agreement.

Indiva Reports First Quarter 2023 Results

Retrieved on: 
Tuesday, May 16, 2023
Natural Resources, Pharmaceutical, Alternative Medicine, Health, Specialty, Food, Beverage, Cannabis, Retail, Dark, Cream, Edible, Pomegranate, Citrus, International, FINANCIAL, Result, Classification, Marketing, Bank statement, Chocolate, Financial condition report, Cannabinoid, Health Canada, Conversation, OCS, Research, CBG, Sale, Granny Smith, CBN, Limited, EBITDA, Cannabis and impaired driving, Patient, International Financial Reporting Standards, Risk, Analysis, SEDAR, CBD, Management, Growth, Ageing, THC, Three Months, News, Automation, Legislation, Cryptocurrency, Fine chemical, Pharmaceutical industry, Oil, Maple syrup, Security (finance), Pearl, Tilray, Indiva

Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the first fiscal quarter ended March 31, 2023.

Key Points: 
  • Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the first fiscal quarter ended March 31, 2023.
  • Baked Goods: Indiva led the baked goods category with 61.0% sub-category share, driven by the success of Indiva Life Double-Stuffed Sandwich Cookies.
  • Product ranking in Q1 2023 showed two of the Top 10 edible SKUs are from Indiva.
  • OPERATING AND FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2023 AND 2022

Indiva Reports Record Fiscal Year 2022 Results

Retrieved on: 
Tuesday, April 18, 2023
Natural Resources, Pharmaceutical, Alternative Medicine, Health, Specialty, Food, Beverage, Cannabis, Retail, Melon, Midnight, Cream, Classification, Marketing, Sandwich, Wild cherry, TWELVE, Patient, Analysis, Ageing, Health Canada, News, Bhang, Automation, Edible, Pomegranate, Lemonade, FINANCIAL, Research, CBG, CBN, Limited, SEDAR, Growth, Consolidated, THC, Legislation, Loss, International, Financial condition report, Financial statement, Capsule, Granny Smith, CBD, Result, Bank statement, Cannabinoid, Stock, EBITDA, White chocolate, Sunset, Dime, Cryptocurrency, Pharmaceutical industry, Video game, Dietary supplement, Tea, Candy, Security (finance), Medical device, Oil, Indiva, Vanilla, Pearl, Tilray

Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022.

Key Points: 
  • Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022.
  • “We are pleased to report record revenue and record gross profit for the fiscal year 2022.
  • In 2022, Indiva introduced several new products from in-house innovation under the Indiva Life brand including Lozenges, Chocolates, Capsules and Sandwich Cookies.
  • Indiva also led the baked goods category with 49.6% sub-category share which includes recently launched Indiva Life Double-Stuffed Cookies.

PRODUCT UPDATE ON INDIVA LOZENGES

Retrieved on: 
Tuesday, March 14, 2023
THC, Edible, Health Canada, Classification, Research, Legislation, Life, Cryptocurrency, Medical device, Indiva

LONDON, ON, March 14, 2023 /PRNewswire/ - Indiva Limited (the "Company" or "Indiva") (TSXV: NDVA), announced that it has received notification from Health Canada (the "Notice") of its determination that certain of its lozenges have been improperly classified as an "extract" rather than an "edible" under applicable cannabis regulations.

Key Points: 
  • LONDON, ON, March 14, 2023 /PRNewswire/ - Indiva Limited (the "Company" or "Indiva") (TSXV: NDVA), announced that it has received notification from Health Canada (the "Notice") of its determination that certain of its lozenges have been improperly classified as an "extract" rather than an "edible" under applicable cannabis regulations.
  • Heath Canada has requested that Indiva cease production of the lozenges.
  • The lozenges subject to this determination are the Indiva Wild Cherry THC Lozenges and Life Lemon THC Lozenges in their 100 mg, 250 mg and 500 mg THC per package formats (the "Products").
  • Prior to the launch of the Products, the Company closely considered the regulatory requirements of the legislation, including with respect to product classification, and conducted substantial research.